ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

640
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
bullish•Quantitative Analysis
•21 Jun 2020 08:11

Asia Short Interest Weekly - Covering HK Consumer Discretionary, Shorting Japan Consumer Staples

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
410 Views
Share
bearish•Quantitative Analysis
•13 Jun 2020 10:42

Asia Short Interest Weekly - Shorts Covered as Markets Melted Up

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
559 Views
Share
bullish•Takeda Pharmaceutical
•12 Jun 2020 16:26

Takeda Offloads Asia-Focused Drugs to South Korea’s Celltrion

The Japanese drug maker, Takeda Pharmaceutical (4502 JP)  announced yesterday (11th June 2020) that it has entered into an agreement to divest a...

Share
bearish•Quantitative Analysis
•07 Jun 2020 09:58

Asia Short Interest Weekly - Massive Short Increase on Meituan, Geely

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
447 Views
Share
bullish•Celltrion Healthcare
•27 May 2020 03:25

Celltrion H Block Deal: Terms, Overhang, Arb Yield, & Post-Deal Trade Angle

Terms & overhangHere is another deal by OEP on Celltrion Healthcare. 4M shares are on the table (2.64% of the SO). The seller set the discount...

Logo
438 Views
Share
x